Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1,001 - 1,050 out of 11,422

Document Document Title
WO/2007/017546A3
The invention relates to a method of obtaining tryptamine derivatives (I), wherein R is a radical of a heterocycle, comprising the decarboxylation of the corresponding derivative of 3-(2-aminoethyl)-1H-indole carboxylic acid and the subs...  
WO/2007/016979A3
The present invention relates to compounds of the general formula (III) or pharmaceutically acceptable salts thereof with an acid or a base, or pharmaceutically acceptable prodrugs or a stereoisomer thereof, Formula (III) wherein R3 is H...  
WO2006021420B1
The invention relates to a method for producing diarylcycloalkyl derivatives of general formula (I), wherein the radicals have the indicated meanings. The invention further relates to novel intermediate products that are formed by means ...  
WO/2007/015809A3
Compounds having the structure: are HIV reverse transcriptase inhibitors, wherein A, X, Y, Z, R1 and R2 are defined herein. The compounds and their pharmaceutically acceptable salts are useful in the inhibition of HIV reverse transcripta...  
WO2006069811B1
Compounds of Formula (4) or (5) that absorb ultraviolet light 380 nm to 400 nm range but avoid absorption in the blue light range, thereby imparting yellowness, i.e., 410-420 nm: have suitable refractive characteristics useful in the pre...  
WO/2007/015533A1
Disclosed is a novel amidine compound which can serve as an active ingredient of a highly safe herbicide which shows a reliable effect at a low dose. Also disclosed is a herbicide comprising the compound as an active ingredient. An amidi...  
WO/2007/013694A1
A compound represented by the general formula (I): (I) wherein each symbol is as defined in the description. The compound is excellent in the effect of decreasing the blood glucose level and the blood lipid level, and therefore is useful...  
WO/2007/014023A1
The present invention relates to certain single-enantiomer pyrrazol-4-yl derivatives of thiazolidinones, oxazolidinones, and pyrrolidinones which are useful in the treatment of Hepatitis B virus.  
WO/2007/014290A3
This invention is directed to compounds of Formula (1) including all geometric and stereoisomers, N oxides, and agriculturally suitable salts thereof, agricultural compositions containing them and their use as fungicides, (1) provided th...  
WO/2007/009389A3
The present invention provides compounds of formula (I), the preparation thereof and their use as peroxisome proliferator activated receptor-γ (PPAR-γ) agonist in the treatment of diabetes and diabetic complications.  
WO/2007/010653A1
A salt molten at room temperature that does not contain any organic solvent, excelling in stability; and a display device that is improved in the durability in high-temperature environment by virtue of the use thereof. There is provided ...  
WO/2007/009389A2
The present invention provides compounds of formula (I), the preparation thereof and their use as peroxisome proliferator activated receptor-γ (PPAR-γ) agonist in the treatment of diabetes and diabetic complications.  
WO2006110155B1
Novel crystalline forms of Linezolid, designated as Form TIII, Form V, Form VI, Form IX, Form X, Form XII, Form XIV, Form XVII, and Form XVIII, are disclosed. The novel crystalline forms are characterized by powder X-ray diffraction, FTI...  
WO/2007/005583A1
The present invention provides methods for preparing TLR-4 receptor agonist E6020 formula(I): and stereoisomers thereof, which compounds are useful as an immunological adjuvants when co-administered with antigens such as vaccines for bac...  
WO/2007/005531A3
Non-nucleoside inhibitors of HIV-I reverse transcriptase are described. Such inhibitors may be used as part of a combination therapy to treat HIV infection. Compounds described herein exhibit antiviral potency. In addition, compounds des...  
WO/2007/005572A1
An efficient process is disclosed for producing a compound that is an inhibitor of CETP. The last step of the process is the coupling of an oxazolidinone derivative with a biphenyl moiety to provide a compound of formula (I). In a specif...  
WO/2007/003419A1
The invention provides Compounds of formula (I) or pharmaceutically acceptable esters, amides, solvates or salts thereof, including salts of such esters or amides, and solvates of such esters, amides or salts, wherein R3, R4, G, Y, W and...  
WO/2007/005531A2
Non-nucleoside inhibitors of HIV-I reverse transcriptase are described. Such inhibitors may be used as part of a combination therapy to treat HIV infection. Compounds described herein exhibit antiviral potency. In addition, compounds des...  
WO/2007/004032A1
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt as antibacterial agents.  
WO/2007/005000A1
The invention relates to methods of synthesizing 2-substituted azole compunds of formula (I). The invention is also relates to compounds of formula (I) and to intermediate compounds in the synthesis method.  
WO/2007/002173A1
One aspect of the invention relates to the design, synthesis and biological activity of novel HIV-1 protease inhibitors incorporating N-phenyloxazolidine-5-carboxamides into the (hydroxyethylamino)sulfonamide scaffold as P2 ligands. For ...  
WO2005012297A9
Leukotriene A4 hydrolase (LTA4H) inhibitors of Formula (I), compositions containing them, and their use for the inhibition of LTA4H enzyme activity and the treatment, prevention or inhibition of inflammation and/or conditions associated ...  
WO/2007/000235A1
The invention relates to alkoxymethyl-substituted benzoic acid derivatives and to the physiologically compatible salts thereof and physiologically functional derivatives thereof. The invention also relates to compounds of formula (I), wh...  
WO2006091848A3
The present invention provides an isolated linezolid (1) impurity, bis-linezolid (4), preparation thereof and its use as a reference standard.  
WO2005087752A8
The invention relates to novel aminoalkanol derivatives and also to methods of treating at least one disease, disorder, or condition associated with amyloidosis using such compounds. Amyloidosis refers to a collection of diseases, disord...  
WO/2006/138660A3
The invention relates to substituted adamantane compounds of formula (I), pharmaceutical compositions thereof, processes for their preparation, and methods for inhibiting sphingosine kinase and for treating or preventing hyperproliferati...  
WO/2006/138328A1
The present invention provides a convergent process for the preparation of a family of antidiabetic phenoxy-substituted phenoxybenzyl oxazolidinediones shown as structure I. The compounds are selective PPAR gamma partial agonists (SPPARM...  
WO2005072376A3
One aspect of the present invention relates to ionic liquids comprising an anionic sweetener. Another aspect of the present invention relates to the use of an ionic liquid of the present invention comprising a pendant Bronsted-acidic gro...  
WO2006082597A3
The present invention discloses crystalline Polymorphic Form I of compound 5-(3,5- dimethylphenoxy-) methyl)-2-oxazolidinone, characterized by x-ray diffraction pattern having peaks at 10.355, 14.285,18.625, 19.030, 20.810 and 22.475± 0...  
WO2006047438A3
Certain novel 3-(dihaloalkenyl)phenyl derivatives have unexpected insecticidal activity. These compounds are represented by formula (I), where R through R5, a, b, D, E, G and U are fully described herein. In addition, compositions compri...  
WO/2006/134955A1
A compound represented by the general formula (1) or (100), a salt thereof or a hydrate of the compound or salt, which is excellent in cell adhesion-inhibitory effect and cell infiltration-inhibitory effect: (1) (100) wherein R10 represe...  
WO2006069154A3
The present invention relates to novel, non-secosteroidal, phenyl-benzoxazole compounds of Formula (I) wherein the variables R, R', RP, RP3, LP1, LP2, ZP, RB, RB', LXB and ZXB are as hereinafter defined, their preparation, pharmaceutical...  
WO/2006/132173A1
Disclosed is an organic electroluminescent device (organic EL device) having an improved luminous efficiency, an adequate driving stability and a simple structure. Also disclosed is an organic metal complex suitable for such an organic e...  
WO/2006/133216A2
This invention relates to non-steroidal compounds that are modulators of androgen, glucocorticoid, mineralocorticoid, and progesterone receptors, and also to the methods for the making and use of such compounds.  
WO/2006/133216A3
This invention relates to non-steroidal compounds that are modulators of androgen, glucocorticoid, mineralocorticoid, and progesterone receptors, and also to the methods for the making and use of such compounds.  
WO2006102674A3
Various azetidinone, pyrrolidine, imidazolidine, and oxazolidine derivative are described, as are pharmaceutical compositions containing these compound and their use for preparing medicaments for the treatment of hypercholesterolemia  
WO/2006/131233A1
The invention relates to benzooxazole-2-on derivatives of general formula (I) with the meanings indicated in the description, the pharmaceutically usable salts thereof, and the use thereof as medicinal substances.  
WO/2006/133326A1
Compounds having the structure of formula I are described. The compounds can inhibit hepatitis C virus (HCV) replication, and in particular can inhibit the function of the HCV NS5A protein.  
WO2006058088A3
In accordance with the present invention, compounds that inhibit the expression of VEGF post-transcriptionally have been identified, and methods for their use provided. In one aspect of the invention, compounds and compositions useful in...  
WO/2006/129164A1
This invention provides a compound of the formula (I): wherein A=B=D represents NR10-C(O)-NR9, S-C(O)-NR9, NR9-C(O)-S, NR9-C(O)-O, CR10-C(O)-NR9, 0-C(O)-NR9, NR10-C(O)-CR9, NR10-NR9-C(O), C(O)-NR9-NR10, NR10-N=CR9, N=N-CR9, NR10-CR9=N, N...  
WO/2006/129649A1
A process for producing optically active butyric acid compounds and intermediates for the production of the compounds in high yields at high optical purities. A process for the production of compounds (6), characterized by comprising pre...  
WO2006017409A3
Compounds represented by Formula I: (wherein A, B, D, P, Q, R1, R2, R3, W and Y are described herein) or pharmaceutically acceptable salts thereof, are effective as NMDA/NR2B antagonists useful for treating neurological conditions such a...  
WO/2006/127503A3
The present invention provides compounds useful, for example, for modulating insulin levels in a subject, having the general formula I: wherein Q is an optionally substituted phenyl; L is a bond or O; P is a benzene or an optionally subs...  
WO2006103045B1
The present invention relates to compounds comprising an oxazole or thiazole moiety of formula (I), processes for preparing them, pharmaceutical compositions comprising said compounds and their uses as H3 -receptor ligands, Formula (I), ...  
WO/2006/127909A3
The present invention relates to polymorphic forms of ( S ) -l-cyanobutan-2-yl ( S ) -1- ( 3 - ( 3 - ( 3 -methoxy-4- ( oxazol-5- yl ) phenyl ) urei do ) phenyl ) ethyl carbamate , pharmaceutical compositions thereof , processes to prepar...  
WO2006110155A8
Novel crystalline forms of Linezolid, designated as Form TIII, Form V, Form VI, Form IX, Form X, Form XII, Form XIV, Form XVII, and Form XVIII, are disclosed. The novel crystalline forms are characterized by powder X-ray diffraction, FTI...  
WO/2006/127503A2
The present invention provides compounds useful, for example, for modulating insulin levels in a subject, having the general formula I: wherein Q is an optionally substituted phenyl; L is a bond or O; P is a benzene or an optionally subs...  
WO2006094770A3
The present invention is directed to a process for the preparation of (4S)- or (4R)-2,2-dimethyl-4-(2-hydroxethyl)oxazolidine-3-carboxylic acid alkyl esters. The invention is further directed to an intermediate product from which those a...  
WO/2006/127893A2
The present invention relates to processes for the production of 4-(biphenylyl)azetidin-2-one phosphonic acid derivatives of formula.  
WO/2006/127893A3
The present invention relates to processes for the production of 4-(biphenylyl)azetidin-2-one phosphonic acid derivatives of formula.  

Matches 1,001 - 1,050 out of 11,422